Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL

Author:  ["Alexei Degterev","Alexey Lugovskoy","Michael Cardone","Bradley Mulley","Gerhard Wagner","Timothy Mitchison","Junying Yuan"]

Publication:  Nature Cell Biology

CITE.CC academic search helps you expand the influence of your papers.

Tags:  general   CellBiology   CancerResearch   DevelopmentalBiology   StemCells   Biological

Abstract

To study the role of the BH3 domain in mediating pro-apoptotic and anti-apoptotic activities of Bcl-2 family members, we identified a series of novel small molecules (BH3Is) that inhibit the binding of the Bak BH3 peptide to Bcl-xL. NMR analyses revealed that BH3Is target the BH3-binding pocket of Bcl-xL. Inhibitors specifically block the BH3-domain-mediated heterodimerization between Bcl-2 family members in vitro and in vivo and induce apoptosis. Our results indicate that BH3-dependent heterodimerization is the key function of anti-apoptotic Bcl-2 family members and is required for the maintenance of cellular homeostasis.

Cite this article

Degterev, A., Lugovskoy, A., Cardone, M. et al. Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL. Nat Cell Biol 3, 173–182 (2001). https://doi.org/10.1038/35055085

View full text

>> Full Text:   Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL

Growth-factor-dependent mitogenesis requires two distinct phases of signalling

Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3